Alkermes Public Limited Company ALKS
NASDAQ · United States · Health Technology
$40.76+0.23 (+0.58%)
Market open· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Market open· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
| Quarter | Report date | Actual EPS | Estimated EPS | EPS surprise | Actual revenue | Revenue surprise | Price reaction |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 2026-07-28 | 0.00 | -0.03 | +100.0% | $496.01M | +8.4% | -8.3%$52.73→$48.34 |
| Q1 2026 | 2026-05-05 | 0.38 | -0.04 | +1,050.0% | — | — | +3.4%$34.17→$35.32 |
| Q4 2025 | 2026-02-25 | 0.48 | 0.45 | +6.7% | — | — | -8.0%$33.39→$30.73 |
| Q3 2025 | 2025-10-28 | 0.65 | 0.39 | +66.7% | — | — | +5.8%$29.72→$31.45 |
| Q2 2025 | 2025-07-29 | 0.68 | 0.40 | +70.0% | — | — | — |
| Q1 2025 | 2025-05-01 | 0.29 | 0.24 | +20.8% | — | — | — |
| Q4 2024 | 2025-02-12 | 1.05 | 0.76 | +38.2% | — | — | — |
| Q3 2024 | 2024-10-24 | 0.73 | 0.71 | +2.8% | — | — | — |
The price reaction is the change from the last close before the announcement date to the first close after it - the report may land before the open, during the session or after the close, so this window covers all three. Not investment advice.